Loading...
Biodexa Pharmaceuticals Plc
BDRX•NASDAQ
Healthcare
Biotechnology
$6.70
$-1.15(-14.65%)
Biodexa Pharmaceuticals Plc (BDRX) Financial Performance & Income Statement Overview
Review Biodexa Pharmaceuticals Plc’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
0.00%
Operating Income Growth
0.00%
Net Income Growth
0.00%
Operating Cash Flow Growth
-79.62%
↓ 79.62%
Operating Margin
0.00%
Gross Margin
0.00%
Net Profit Margin
0.00%
ROE
-67.21%
↓ 67.21%
ROIC
-94.39%
↓ 94.39%
Biodexa Pharmaceuticals Plc (BDRX) Income Statement & Financial Overview
Review Biodexa Pharmaceuticals Plc's (BDRX) income statement with detailed quarterly and annual figures.
| Metric | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $0.00 | $41500.00 | $41500.00 | $149000.00 |
| Cost of Revenue | $0.00 | $1.13M | $1.13M | $1.13M |
| Gross Profit | $0.00 | -$1.08M | -$1.08M | -$976500.00 |
| Gross Profit Ratio | $0.00 | -$26.12 | -$26.12 | -$6.55 |
| R&D Expenses | $2.19M | $908000.00 | $908000.00 | $1.13M |
| SG&A Expenses | $2.03M | $370500.00 | $370500.00 | $1.15M |
| Operating Expenses | $4.22M | $801000.00 | $3.002M | $952499.00 |
| Total Costs & Expenses | $4.22M | $1.93M | $4.13M | $2.08M |
| Interest Income | $88000.00 | $20000.00 | $20000.00 | $1000.00 |
| Interest Expense | $49000.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $136000.00 | $36500.00 | $36500.00 | $36500.00 |
| EBITDA | -$3.25M | -$1.14M | -$1.14M | -$2.09M |
| EBITDA Ratio | $0.00 | -$27.55 | -$27.55 | -$14.00 |
| Operating Income | -$4.22M | -$1.89M | -$1.18M | -$2.12M |
| Operating Income Ratio | $0.00 | -$45.42 | -$28.43 | -$14.24 |
| Other Income/Expenses (Net) | $790000.00 | $70500.00 | $70500.00 | $194000.00 |
| Income Before Tax | -$3.43M | -$1.81M | -$1.81M | -$1.93M |
| Income Before Tax Ratio | $0.00 | -$43.72 | -$43.72 | -$12.94 |
| Income Tax Expense | -$125000.00 | $59000.00 | $59000.00 | $144000.00 |
| Net Income | -$3.31M | -$1.76M | -$1.76M | -$1.78M |
| Net Income Ratio | $0.00 | -$42.30 | -$42.30 | -$11.97 |
| EPS | -$0.40 | -$32.97 | -$1.32 | -$7.19 |
| Diluted EPS | -$0.40 | -$32.97 | -$1.32 | -$7.19 |
| Weighted Avg Shares Outstanding | $820.00 | $53251.00 | $1.33M | $247978.00 |
| Weighted Avg Shares Outstanding (Diluted) | $8.20M | $53251.00 | $1.33M | $247978.00 |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan